Health Behavior and Health Equity

COVID-19 hits older adults hardest: Which ones want the updated vaccine?

Poll points to some groups of people needing more encouragement from clinicians and other sources to get vaccinated

The newly updated COVID-19 vaccine just arrived in pharmacies and clinics nationwide. Still, a recent poll shows some older adults with high risk of severe illness appear unlikely to seek the vaccine. Interest varies widely by age group, education level, race and ethnicity, and other factors.

College students' mental health improving, more finding support

The latest annual Healthy Minds Study, which surveyed 100,000-plus college students from 200 universities across the United States, has good news to report: There are decreases in symptoms of anxiety, depression and thoughts of suicide, and increases in receiving mental health care and support.

MI-Healthy City Tool helps communities promote health equity across Michigan

The MI-Healthy City Tool, developed by researchers at the University of Michigan School of Public Health, is a comprehensive dashboard analyzing health equity in Michigan's largest cities to inform policy and community action.

Enrique Neblett appointed director of the Detroit URC

U-M Social Work and Public Health professor Katrina Ellis appointed associate director

Neblett, a professor of Health Behavior & Health Equity at the University of Michigan School of Public Health, begins his appointment as director of the Detroit Community-Academic Urban Research Center on September 1.

Paul J. Fleming receives Harold R. Johnson Diversity Service Award

Paul Fleming, an associate professor of Health Behavior & Health Equity and the faculty lead for diversity, equity, and inclusion received an award for his contributions to public health through teaching, community-based research and mentorship.

9 million Medicare beneficiaries to benefit from new drug pricing, but careful monitoring needed, says U-M researcher

Michigan Public Health professor and researcher Minal Patel discusses the US Department of Health and Human Services’ move to lower prices on for 10 high-cost medications for individuals with Medicare Part D coverage.